癌細胞における光化学的に誘発されたpH不均衡による選択的な細胞死
Xiling Yue1, Ciceron O Yanez, Sheng Yao
1Department of Chemistry, University of Central Florida, P.O. Box 162366, Orlando, Florida 32816, USA.
Journal of the American Chemical Society
|January 31, 2013
まとめ
この研究では,光酸生成器 (PAG) を使用した酸素依存の新型光動力療法 (PDT) が紹介されています. これらのPAGは,低酸素がん細胞の細胞死を誘発し,腫瘍治療の有望な代替案を提供します.
科学分野:
- バイオメディカルエンジニアリング
- フォトケミストリー フォトケミストリー
- ガン治療 ガン治療 ガン治療
背景:
- 光ダイナミック療法 (PDT) の有効性は,固体腫瘍における低酸素によって制限されています.
- 酸素に依存する反応性酸素種生成は,低酸素環境での従来のPDTを阻害します.
研究 の 目的:
- 酸素に依存しないPDT戦略を開発する.
- 選択的な癌細胞死に対する光酸生成器 (PAG) の可能性を調査する.
主な方法:
- PAGとして合成されたスルフォニウム塩.
- 細胞内での光酸生成のために1または2フォトンの吸収 (1PA/2PA) を利用した.
- HCT 116細胞でPAG誘発のpH低下と細胞死亡を評価した.
主要な成果:
- PAGは光酸を生成し,HCT 116細胞のpH値低下を引き起こしました.
- 1つのPAGは,低濃度のダークサイト毒性と効率的な光酸生成を示した.
- 低毒性細胞では,死滅性細胞死の効果的な誘導が観察されました.
結論:
- PAGは,酸素に依存しないPDTのアプローチを可能にします.
- この方法は,低毒性腫瘍における選択的な癌細胞殺戮の可能性を示しています.
- PAGは,酸素不足の組織を治療するための魅力的な代替手段です.
さらに関連する動画
05:18Selective Cell Elimination from Mixed 3D Culture Using a Near Infrared Photoimmunotherapy Technique
Published on: March 14, 2016
13:17In Vitro and In Vivo Evaluation of Photocontrolled Biologically Active Compounds - Potential Drug Candidates for Cancer Photopharmacology
Published on: September 29, 2023
関連する概念動画
01:30Overview of Cell Death
Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:36DNA Damage Can Stall the Cell Cycle
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
02:36DNA Damage can Stall the Cell Cycle
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
01:31The Intrinsic Apoptotic Pathway
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...